RIVERSIDE MEDICAL CENTER — History
CCN 140186 | 3-year financial timeline | COVID resilience: 52/100
🛡️ Public data only — no PHI permitted on this instance.
$389M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
-6.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $356M | $396M | $389M | -1.8% | +4.5% |
| Operating Expenses | $371M | $397M | $414M | +4.2% | +5.7% |
| Operating Margin | -4.0% | -0.3% | -6.4% | -1799.7% | +0.0% |
| Net Income | $-14M | $-1M | $-25M | -1766.4% | +0.0% |
| Licensed Beds | 256 | 256 | 256 | +0.0% | +0.0% |
| Total Patient Days | 45,004 | 47,706 | 39,534 | -17.1% | -6.3% |
| Medicare Day % | 33% | 30% | 28% | -3.7% | -7.3% |
| Medicaid Day % | 14% | 7% | 12% | +59.8% | -10.5% |
COVID Impact & Recovery
Resilience Score: 52/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.2% ($356M → $389M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
-6.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $406M | -7.7% |
| FY2024 (proj) | $422M | -8.9% |
| FY2025 (proj) | $438M | -10.1% |